Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.5.0.2
Statements of Operations - USD ($)
2 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2016
Revenue $ 0 $ 0 $ 0
Operating expenses:      
Research and development 38,409 496,659 616,498
General and administrative 184,344 924,041 1,847,613
Depreciation 0 977 1,629
Total operating expense 222,753 1,421,677 2,465,740
Loss from operations (222,753) (1,421,677) (2,465,740)
Other expense:      
Interest expense (1,562) (10,402) (37,307)
Net loss $ (224,315) $ (1,432,079) $ (2,503,047)
Net loss per common share - basic and diluted (in dollars per share) $ (0.05) $ (0.12) $ (0.28)
Weighted average common shares outstanding - basic and diluted (in shares) 4,320,015 11,579,239 9,066,804